DuPont de Nemours Inc (DD)

Industry Specialty Chemicals


This stock can be held in an Investment ISA and an Investment Account
Sell

$42.50

Buy

$45.55

arrow-down$-0.73 (-1.58%)

Prices updated at 03 Apr 2026, 00:56 EDT
| Prices minimum 15 mins delay
|
Prices in USD

DowDuPont Inc is jointly owned by Dow and DuPont for the purpose of forming publicly traded companies in the agriculture, materials science and specialty products sectors.

Income statement

20242025
6,719m6,849m
2,220m2,363m
747m860m
11.1212.56
703m-779m
1,118m1,160m
Sales, General and administrative976m1,019m
Interest expenses366m313m
Provision for income taxes213m102m
Operating expenses1,473m1,503m
Income before taxes117m200m
Net income available to common shareholders703m-779m
1.68-1.87
Net interest income-292m-215m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)1.67-1.87
Free cash flow per share2.92833.1339
Book value/share57.924255.9488
Debt equity ratio0.2279660.22516

Balance sheet

20242025
Current assets6,364m5,575m
Current liabilities4,801m2,305m
Total capital28,673m17,044m
Total debt7,171m3,194m
Total equity23,350m13,919m
Total non current liabilities--
Loans5,323m3,125m
Total assets36,636m21,575m
Total liabilities--
Cash and cash equivalents1,850m715m
Common stock418m409m

Cash flow

20242025
Cash at beginning of period2,803m1,892m
Cash dividends paid-635m-597m
1,421m172m
Investments (gains) losses-849m-374m
1,892m760m
Net income--
2,321m560m
-900m-388m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.